Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q3 FY19 results · Oct–Dec 2018
Caplin Point Laboratories reported revenue from operations of ₹139.76 crore and net profit of ₹36.86 crore for Q3 FY19 (Oct–Dec 2018), on a standalone basis.
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 139.76 | — | — | 131.24 | +6.5% |
| Other income | 7.37 | — | — | 6.67 | +10.5% |
| Total income | 147.13 | — | — | 137.91 | +6.7% |
| Profit before tax | 50.86 | — | — | 43.32 | +17.4% |
| Net profit for the period | 36.86 | — | — | 29.62 | +24.4% |
| EPS, basic (₹) | 4.88 | — | — | 3.95 | +23.5% |
| Net margin (%) | 26.4 | — | 22.6 |
Standalone
- Filed with BSE
- 12 Feb 2019, 16:56 IST
- Board meeting
- 11 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE